secwatch.observer — SEC 8-K summary
======================================

Issuer:     Keros Therapeutics, Inc. (KROS)
CIK:        0001664710
Form:       8-K
Filed at:   2026-08-03T20:07:39+00:00
Accession:  0001664710-26-000050
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Keros Therapeutics files updated corporate presentation; no specific material facts disclosed
--------------------------------------------------------------------------------

- The filing contains no specific new material information beyond a routine corporate presentation update.
- The presentation is used for meetings with investors, analysts, and others.
- No financial results, clinical data, or guidance changes were disclosed in the filing.
- The exhibit text provided is truncated and does not contain complete details.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1664710/000166471026000050/0001664710-26-000050-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1664710/000166471026000050/kros-20260803.htm
  HTML page:      https://secwatch.observer/filing/0001664710-26-000050

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer